InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Carboat post# 271164

Monday, 08/29/2016 7:03:53 PM

Monday, August 29, 2016 7:03:53 PM

Post# of 345846
Steve King CEO a man ahead of his times and why? Because he knew Academia must be involved and Big Pharma no longer has a stranglehold on all of Academia

Others knew Academia was needed and King brought them on board

http://invivo.msu.edu/Read%20white%20paper.pdf

From Concept Through Approval
http://www.ncbi.nlm.nih.gov/books/NBK50972/?report=reader

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News